Concepedia

Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit

Débora De Melo Gagliato, Denis L. Jardim, Gerald S. Falchook, Chad Tang, Ralph Zinner, Jennifer J. Wheler, Filip Jankú, Vivek Subbiah, Sarina A. Piha‐Paul, Siqing Fu,

Clinical Breast Cancer · 2014 · 43 citations · 32 references

DOIFull text

Open access

Concepts

References

32

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi et al. · Science · 2007 · 4.5K citations · Full text

, , +17

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen et al. · Clinical Cancer Research · 2004 · 2.7K citations · Full text

, , +17

Identification of the Hepatocyte Growth Factor Receptor As the c- <i>met</i> Proto-Oncogene Product

Donald P. Bottaro, Jeffrey S. Rubin, Donna L. Faletto et al. · Science · 1991 · 2.2K citations

, , +15